Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
There are no completed human clinical trials, and this material is supplied strictly as a laboratory research reagent
However, inclusion of affiliate links does not influence the objectivity or accuracy of the information presented
In preclinical research, AOD9604 is primarily investigated for its selective lipolytic activitythe ability to stimulate fat breakdown (lipolysis) and inhibit fat synthesis (lipogenesis) without exhibiting the growth-promoting or diabetogenic effects of full-length growth hormone
These tend to follow the same pattern as nausea, peaking during titration and decreasing over time
Not shut down inflammation completely, because you do not want that either
Retrieved May 1, 2025, from Drugs.com database
